Role of Drugs Used for Chronic Disease Management on Susceptibility and Severity of COVID‐19: A Large Case‐Control Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Drugs Used for Chronic Disease Management on Susceptibility and Severity of COVID‐19: A Large Case‐Control Study
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-22
DOI
10.1002/cpt.2047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- COVID-19 infection: the perspectives on immune responses
- (2020) Yufang Shi et al. CELL DEATH AND DIFFERENTIATION
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension
- (2020) Gang Li et al. HYPERTENSION RESEARCH
- Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
- (2020) Biykem Bozkurt et al. JOURNAL OF CARDIAC FAILURE
- Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
- (2020) Murray Esler et al. JOURNAL OF HYPERTENSION
- Endocrine and metabolic link to coronavirus infection
- (2020) Stefan R. Bornstein et al. Nature Reviews Endocrinology
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drugs and the renin-angiotensin system in covid-19
- (2020) Jeffrey K Aronson et al. BMJ-British Medical Journal
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Inflammatory mediators and lung abnormalities in HIV: A systematic review
- (2019) Breanne M. Head et al. PLoS One
- Prescription Patterns of Angiotensin-Converting Enzyme Inhibitors for Various Indications: A UK Population-based Study
- (2018) Seyed Hamidreza Mahmoudpour et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Status of Hypertension in China
- (2018) Zengwu Wang et al. CIRCULATION
- Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations
- (2018) Aran Singanayagam et al. Nature Communications
- Using big data to improve cardiovascular care and outcomes in China: a protocol for the CHinese Electronic health Records Research in Yinzhou (CHERRY) Study
- (2018) Hongbo Lin et al. BMJ Open
- A novel role for myeloid endothelin-B receptors in hypertension
- (2018) Alicja Czopek et al. EUROPEAN HEART JOURNAL
- Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)
- (2017) Jiapeng Lu et al. LANCET
- Inhibition of Endoplasmic Reticulum-Resident Glucosidases Impairs Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63 Spike Protein-Mediated Entry by Altering the Glycan Processing of Angiotensin I-Converting Enzyme 2
- (2014) Xuesen Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon
- (2014) Belinda J. Thomas et al. Scientific Reports
- Guidelines for the management of hypertension and target organ damage
- (2013) Giuseppe Mancia et al. JOURNAL OF HYPERTENSION
- Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63
- (2012) R. Dijkman et al. JOURNAL OF GENERAL VIROLOGY
- Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
- (2012) D. Caldeira et al. BMJ-British Medical Journal
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now